27.12.2012 Views

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

0174<br />

RELATION BETWEEN LOW PML-RARα LEVELS, FLT3-ITD, OVEREXPRESSION OF CXCR4<br />

GENE AND UNFAVORABLE PROGNOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA<br />

M.C. Chillón, 1 C. Fernández, 1 C. Santamaría, 1 R. García-Sanz, 1<br />

A. Balanzategui, 1 P. Martín-Jiménez, 1 A. Armellini, 1 M. Alcoceba, 1 M.E.<br />

Sarasquete, 1 M. Vargas, 1 F. Ramos, 1 L. Guerras, 2 M. González, 1<br />

J.F. Jesús Fernando 1<br />

1 Hospital Universitario de Salamanca, SALAMANCA; 2 Hospital Clínico de<br />

Valladolid, VALLADOLID, Spain<br />

Background. The quantification <strong>of</strong> PML-RARα fusion transcripts have<br />

become an important part <strong>of</strong> <strong>the</strong> routine clinical practice. Moreover,<br />

<strong>the</strong>re is an increasing interest in gene expression analyses for identifying<br />

different subclasses <strong>of</strong> AML. However, few clinical studies have been<br />

carried out in this way, and <strong>the</strong>re are discrepancies concerning <strong>the</strong>ir prognostic<br />

significance. Aims. 1) To determine <strong>the</strong> correlation <strong>of</strong> PML-RARα<br />

levels, FLT3 mutations and gene expression patterns with pre-treatment<br />

characteristics <strong>of</strong> 141 newly diagnosed APL patients. 2) To evaluate <strong>the</strong><br />

prognostic significance <strong>of</strong> <strong>the</strong>se alterations to identify subsets <strong>of</strong> patients<br />

at increased risk <strong>of</strong> relapse. Methods. Real-time quantitative RQ-PCR<br />

(TaqMan technology) was used. The normalized copy number (NCN)<br />

<strong>of</strong> fusion gene was reported as: number <strong>of</strong> PML-RARα copies per 1×10 4<br />

ABL copies. Genes encoding multi drug resistance proteins (MDR1 and<br />

MRP1), <strong>the</strong> chemokine receptor CXCR4, <strong>the</strong> tyrosine kinase receptor<br />

FLT3 and growth factors upregulated in APL (HGF and FGF13) were<br />

studied. Results. 84 (59.6%), 5 (3.5%) and 52 (36.9%) patients showed<br />

<strong>the</strong> bcr1, bcr2 and bcr3 PML-RARα is<strong>of</strong>orms, respectively. The median<br />

NCN was 4100 with a wide range <strong>of</strong> expression (1100-35000). The low<br />

levels <strong>of</strong> transcripts (NCN

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!